Genetically modified cells: applications for intracerebral grafting (Q36705238)

15 August 2017

1 reference

title

Genetically modified cells: applications for intracerebral grafting (English)

1 reference

15 August 2017

F. H. Gage

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1721735

8 November 2022

M. D. Kawaja

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1721735

8 November 2022

L. J. Fisher

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1721735

8 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1721735

8 November 2022

publication date

1 August 1991

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:016622369190156O?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

https://api.elsevier.com/content/article/PII:016622369190156O?httpAccept=text/plain

8 November 2022

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

8 November 2022

published in

Trends in Neurosciences

1 reference

15 August 2017

volume

14

1 reference

15 August 2017

issue

8

1 reference

15 August 2017

page(s)

328-333

1 reference

Progress toward human gene therapy

15 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

ADA deficiency: a prime candidate

8 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Grafting genetically modified cells to the brain: possibilities for the future

8 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression

8 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Grafting genetically modified cells into the rat brain: characteristics of E. coli beta-galactosidase as a reporter gene

8 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Synthesis of L-3,4-dihydroxyphenylalanine by tyrosine hydroxylase cDNA-transfected C6 cells: application for intracerebral grafting

8 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Behavioural Effect of Engineered Cells that Synthesize l-dopa or Dopamine after Grafting into the Rat Neostriatum

8 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

In vivo release of dopa and dopamine from genetically engineered cells grafted to the denervated rat striatum

8 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF.

8 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor

8 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

The use of cell lines in neurobiology

8 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Amitotic neuroblastoma cells used for neural implants in monkeys

8 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line

8 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Retrovirus-mediated gene transfer into mouse cerebellar primary culture and its application to the neural transplantation

8 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

8 November 2022

Gene therapeutics

18

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections

8 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration.

8 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey.

8 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor

8 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Nerve growth factor receptor and choline acetyltransferase colocalization in neurons within the rat forebrain: response to fimbria-fornix transection

8 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Intracerebral grafting of genetically modified cells acting as biological pumps

8 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Morphological response of axotomized septal neurons to nerve growth factor

8 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

8 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants

8 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Brain Grafts Reduce Motor Abnormalities Produced by Destruction of Nigrostriatal Dopamine System

8 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour

8 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Implantation of PC12 cells into the corpus striatum of rats with lesions of the dopaminergic nigrostriatal neurons

8 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Properties of PC12 pheochromocytoma cells transplanted to the adult rat brain

8 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Transplantation of B16/C3 melanoma cells into the brains of rats and mice

8 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Biochemical properties of monoamine-rich human neuroblastoma cells

8 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Tetrahydrobiopterin-dependent production of L-dopa in NRK fibroblasts transfected with tyrosine hydroxylase cDNA: future use for intracerebral grafting

8 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Genetically altered and defined cell lines for transplantation in animal models of Parkinson's disease

8 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Neural transplantation using temperature-sensitive immortalized neural cells: a preliminary report

8 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopa

8 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

8 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Potential use of nerve growth factor to treat Alzheimer's disease

8 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

Cellular replacement therapy for neurologic disorders: potential of genetically engineered cells

8 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0166-2236(91)90156-O

8 November 2022

Identifiers

1 reference

15 August 2017

1 reference